Walleye Trading’s Aegerion Pharmaceuticals AEGR Stock Holding History

Walleye Trading’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,376	Closed	-$16K	–	5564
2016 Q3	$16K	Sell	5,376 -7,700	-59%	-$13.3K	﹤0.01%	4279
2016 Q2	$19K	Buy	13,076 +12,512	+2,218%	+$28.6K	﹤0.01%	4603
2016 Q1	$2K	Sell	564 -5,388	-91%	-$33.4K	﹤0.01%	5157
2015 Q4	$60K	Buy	5,952 +4,078	+218%	+$49.1K	﹤0.01%	3728
2015 Q3	$25K	Buy	+1,874	New	+$33.4K	﹤0.01%	3957

Walleye Trading's AEGR Position: Q4 2016 in Review

Walleye Trading sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 5,376 shares — an estimated $16K sold.

Walleye Trading first reported a position in AEGR in Q3 2015 and held it in 5 quarters. The position peaked at $60K in Q4 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Walleye Trading reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Walleye Trading sold 5,376 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $16K.
Walleye Trading first reported a position in Aegerion Pharmaceuticals in Q3 2015 and held it in 5 quarters.
Walleye Trading's Aegerion Pharmaceuticals position peaked at $60K in Q4 2015.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Walleye Trading's 13F filing for Q4 2016, filed 14 Feb 2017.